Intuitive Surgical, Inc. (ISRG) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
"main_header": {
"sid": 1156178,
"name": "Intuitive Surgical, Inc.",
"stock_name": "Intuitive Surgical, Inc.",
"full_name": "Intuitive Surgical, Inc.",
"name_url": "stocks-analysis/intuitive-surgical-inc",
"exchange": 210,
"exchangecode": "NAS",
"country_id": 2,
"currency": "USD",
"cmp": "568.63",
"chg": 0.91,
"chgp": "0.16%",
"dir": 1,
"prev_price": "567.72",
"mcapval": "168,483.96",
"mcap": "Large Cap",
"scripcode": "",
"symbol": "",
"ind_name": "Pharmaceuticals & Biotechnology",
"ind_code": 2325,
"indexname": "S&P 500",
"isin": "US46120E6023",
"curr_date": "Dec 04",
"curr_time": "",
"bse_nse_vol": "2.3 M",
"exc_status": "Active",
"traded_date": "Dec 04, 2025",
"traded_date_str": "2025 12 04",
"score": "",
"scoreText": "",
"Live": 0,
"market_time": 0,
"is_blur": 1,
"is_blur_class": "blur-registerF-score-header",
"is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/intuitive-surgical-inc-1156178-210&utm_source=Spage_Header_Score",
"mojoone": {
"ismore": 0
}
},
"news": {
"results": [
{
"title": "Is Intuitive Surgical, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-intuitive-surgical-inc-technically-bullish-or-bearish-3651336",
"imagepath": "",
"date": "2025-10-28 11:40:49",
"description": "As of 24 October 2025, the technical trend for Intuitive Surgical, Inc. has changed from mildly bearish to sideways. The current stance is neutral, with mixed signals across different indicators. The weekly MACD is mildly bullish, while the monthly MACD is mildly bearish. Bollinger Bands show bullish signals for both weekly and monthly periods. However, moving averages are mildly bearish on the daily timeframe, and KST is bearish for both weekly and monthly periods. The Dow Theory indicates a mildly bullish stance on the weekly but mildly bearish on the monthly. \n\nIn terms of performance, Intuitive Surgical has significantly outperformed the S&P 500 over the past week (22.50% vs. 1.92%) and month (23.09% vs. 2.32%), but it lags behind in year-to-date (4.70% vs. 15.47%) and one-year returns (6.82% vs. 16.90%). Overall, the mixed indicators suggest a cautious approach...."
},
{
"title": "Is Intuitive Surgical, Inc. overvalued or undervalued?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-intuitive-surgical-inc-overvalued-or-undervalued-3651067",
"imagepath": "",
"date": "2025-10-28 11:12:04",
"description": "As of 24 October 2025, the valuation grade for Intuitive Surgical, Inc. has moved from very expensive to expensive. The company appears to be overvalued based on its high valuation ratios, including a P/E ratio of 80, a Price to Book Value of 11.67, and an EV to EBITDA of 66.13. In comparison, peers such as Abbott Laboratories and Thermo Fisher Scientific, Inc. have significantly lower P/E ratios of 18.36 and 30.06, respectively, indicating that Intuitive Surgical is trading at a premium relative to its industry.\n\nDespite the overvaluation, Intuitive Surgical has shown strong recent performance, with a 3-year return of 148.11%, which outpaces the S&P 500's return of 78.85% over the same period. However, its year-to-date return of 4.70% lags behind the S&P 500's 15.47%, reinforcing the notion that the stock may be overvalued in the current market context...."
},
{
"title": "Is Intuitive Surgical, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-intuitive-surgical-inc-technically-bullish-or-bearish-3647790",
"imagepath": "",
"date": "2025-10-27 11:51:58",
"description": "As of 24 October 2025, the technical trend for Intuitive Surgical, Inc. has changed from mildly bearish to sideways. The current stance is neutral, with mixed signals across different indicators. The weekly MACD is mildly bullish, while the monthly MACD is mildly bearish. The Bollinger Bands indicate bullish conditions on both weekly and monthly time frames. However, the daily moving averages are mildly bearish, and the KST shows bearish signals on both weekly and monthly charts. The Dow Theory reflects a mildly bullish stance weekly but is mildly bearish monthly. \n\nIn terms of performance, Intuitive Surgical has outperformed the S&P 500 over the past week and month, with returns of 22.50% and 23.09% compared to the S&P 500's 1.92% and 2.32%, respectively. However, year-to-date and one-year returns are lagging behind the benchmark. Overall, the mixed indicators suggest a cautious approach...."
},
{
"title": "Is Intuitive Surgical, Inc. overvalued or undervalued?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-intuitive-surgical-inc-overvalued-or-undervalued-3647574",
"imagepath": "",
"date": "2025-10-27 11:12:17",
"description": "As of 24 October 2025, the valuation grade for Intuitive Surgical, Inc. has moved from very expensive to expensive, indicating a slight improvement in perceived value but still suggesting overvaluation. The company is considered overvalued based on its high valuation ratios, including a P/E ratio of 80, an EV to EBITDA of 66.13, and a PEG ratio of 3.60. Comparatively, Abbott Laboratories and Thermo Fisher Scientific, Inc. have P/E ratios of 18.36 and 30.06, respectively, highlighting the premium at which Intuitive Surgical is trading.\n\nDespite its strong performance, with a 3-year return of 148.11% compared to the S&P 500's 78.85%, the high valuation metrics suggest that the stock may not be a prudent investment at current levels. The company's returns have outpaced the benchmark in the short term, but the elevated valuation ratios raise concerns about future growth sustainability...."
},
{
"title": "Is Intuitive Surgical, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-intuitive-surgical-inc-technically-bullish-or-bearish-3646325",
"imagepath": "",
"date": "2025-10-26 11:26:36",
"description": "As of 24 October 2025, the technical trend for Intuitive Surgical, Inc. has changed from mildly bearish to sideways. The current stance is neutral, with mixed signals across different indicators. The weekly MACD is mildly bullish, while the monthly MACD is mildly bearish. Bollinger Bands indicate bullishness in both weekly and monthly time frames. However, the daily moving averages are mildly bearish, and the KST shows bearish signals in both weekly and monthly periods. The Dow Theory reflects a mildly bullish stance on the weekly chart but is bearish on the monthly. \n\nIn terms of performance, Intuitive Surgical has outperformed the S&P 500 over the past week and month, with returns of 22.50% and 23.09% respectively, while the S&P 500 returned 1.92% and 2.32%. However, over longer periods, such as YTD and 1Y, the company has underperformed the benchmark. Overall, the mixed indicators suggest a cautious appr..."
},
{
"title": "Is Intuitive Surgical, Inc. overvalued or undervalued?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-intuitive-surgical-inc-overvalued-or-undervalued-3646113",
"imagepath": "",
"date": "2025-10-26 11:08:37",
"description": "As of 24 October 2025, the valuation grade for Intuitive Surgical, Inc. has moved from very expensive to expensive. The company appears overvalued based on its current valuation metrics. Key ratios include a P/E ratio of 80, an EV to EBITDA of 66.13, and a PEG ratio of 3.60, all of which are significantly higher than its peers, such as Abbott Laboratories with a P/E of 18.36 and Thermo Fisher Scientific with an EV to EBITDA of 21.65.\n\nIn comparison to the broader market, Intuitive Surgical has shown strong short-term performance, with a 1-week return of 22.50% compared to the S&P 500's 1.92%, but its year-to-date return of 4.70% lags behind the S&P 500's 15.47%. This suggests that despite recent gains, the company's high valuation ratios indicate it may not be justified given its performance relative to both peers and the market...."
},
{
"title": "Intuitive Surgical Stock Soars 13.89%, Hits Intraday High of $549.85",
"link": "https://www.marketsmojo.com/news/stocks-in-action/intuitive-surgical-stock-soars-1389-hits-intraday-high-of-54985-3641316",
"imagepath": "https://i.marketsmojo.com/newsimg/2025/10/IntuitiveSurgic_priceRelatedfactors_3641316.png",
"date": "2025-10-23 17:32:13",
"description": "Intuitive Surgical, Inc. has seen notable stock activity, with a substantial increase today and impressive gains over the past week and month. The company demonstrates strong long-term growth, high institutional holdings, and solid operational metrics, reflecting its resilience and potential within the Pharmaceuticals & Biotechnology sector."
},
{
"title": "Intuitive Surgical, Inc. Experiences Revision in Its Stock Evaluation Amid Market Challenges",
"link": "https://www.marketsmojo.com/news/stocks-in-action/intuitive-surgicals-valuation-grade-changes-from-expensive-to-fair-amid-price-decline-3617393",
"imagepath": "https://i.marketsmojo.com/newsimg/2025/10/IntuitiveSurgic_valuationdot_3617393.png",
"date": "2025-10-13 15:40:02",
"description": "Intuitive Surgical, Inc. has recently adjusted its valuation, with its stock price at $429.59, down from $443.76. Over the past year, the company has underperformed the S&P 500. Key financial metrics indicate a premium valuation, with a P/E ratio of 80 and a return on capital employed of 19.51%."
},
{
"title": "Is Intuitive Surgical, Inc. overvalued or undervalued?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-intuitive-surgical-inc-overvalued-or-undervalued-3612678",
"imagepath": "",
"date": "2025-10-12 11:08:24",
"description": "As of 10 October 2025, the valuation grade for Intuitive Surgical, Inc. has moved from expensive to fair. The company appears to be fairly valued based on its current metrics, with a P/E ratio of 80, a Price to Book Value of 11.67, and an EV to EBITDA of 66.13. In comparison to peers, Abbott Laboratories has a P/E of 18.36, while Thermo Fisher Scientific, Inc. has a P/E of 30.06, indicating that Intuitive Surgical is trading at a premium relative to these companies.\n\nDespite the recent shift in valuation, Intuitive Surgical has underperformed compared to the S&P 500, with a year-to-date return of -17.70% versus the S&P 500's 11.41%. This underperformance, along with the high valuation ratios, suggests that while the stock is currently fairly valued, it may face challenges in justifying its premium in the near term...."
}
],
"total": 19,
"sid": "1156178",
"stock_news_url": "https://www.marketsmojo.com/news/intuitive-surgical-inc-1156178"
},
"announcements": "",
"corporate_actions": {
"msg": "No corporate action Found"
}
}

News and Views

Is Intuitive Surgical, Inc. technically bullish or bearish?

2025-10-28 11:40:49

As of 24 October 2025, the technical trend for Intuitive Surgical, Inc. has changed from mildly bearish to sideways. The current stance is neutral, with mixed signals across different indicators. The weekly MACD is mildly bullish, while the monthly MACD is mildly bearish. Bollinger Bands show bullish signals for both weekly and monthly periods. However, moving averages are mildly bearish on the daily timeframe, and KST is bearish for both weekly and monthly periods. The Dow Theory indicates a mildly bullish stance on the weekly but mildly bearish on the monthly. In terms of performance, Intuitive Surgical has significantly outperformed the S&P 500 over the past week (22.50% vs. 1.92%) and month (23.09% vs. 2.32%), but it lags behind in year-to-date (4.70% vs. 15.47%) and one-year returns (6.82% vs. 16.90%). Overall, the mixed indicators suggest a cautious approach....

Is Intuitive Surgical, Inc. overvalued or undervalued?

2025-10-28 11:12:04

As of 24 October 2025, the valuation grade for Intuitive Surgical, Inc. has moved from very expensive to expensive. The company appears to be overvalued based on its high valuation ratios, including a P/E ratio of 80, a Price to Book Value of 11.67, and an EV to EBITDA of 66.13. In comparison, peers such as Abbott Laboratories and Thermo Fisher Scientific, Inc. have significantly lower P/E ratios of 18.36 and 30.06, respectively, indicating that Intuitive Surgical is trading at a premium relative to its industry. Despite the overvaluation, Intuitive Surgical has shown strong recent performance, with a 3-year return of 148.11%, which outpaces the S&P 500's return of 78.85% over the same period. However, its year-to-date return of 4.70% lags behind the S&P 500's 15.47%, reinforcing the notion that the stock may be overvalued in the current market context....

Is Intuitive Surgical, Inc. technically bullish or bearish?

2025-10-27 11:51:58

As of 24 October 2025, the technical trend for Intuitive Surgical, Inc. has changed from mildly bearish to sideways. The current stance is neutral, with mixed signals across different indicators. The weekly MACD is mildly bullish, while the monthly MACD is mildly bearish. The Bollinger Bands indicate bullish conditions on both weekly and monthly time frames. However, the daily moving averages are mildly bearish, and the KST shows bearish signals on both weekly and monthly charts. The Dow Theory reflects a mildly bullish stance weekly but is mildly bearish monthly. In terms of performance, Intuitive Surgical has outperformed the S&P 500 over the past week and month, with returns of 22.50% and 23.09% compared to the S&P 500's 1.92% and 2.32%, respectively. However, year-to-date and one-year returns are lagging behind the benchmark. Overall, the mixed indicators suggest a cautious approach....

Is Intuitive Surgical, Inc. overvalued or undervalued?

2025-10-27 11:12:17

As of 24 October 2025, the valuation grade for Intuitive Surgical, Inc. has moved from very expensive to expensive, indicating a slight improvement in perceived value but still suggesting overvaluation. The company is considered overvalued based on its high valuation ratios, including a P/E ratio of 80, an EV to EBITDA of 66.13, and a PEG ratio of 3.60. Comparatively, Abbott Laboratories and Thermo Fisher Scientific, Inc. have P/E ratios of 18.36 and 30.06, respectively, highlighting the premium at which Intuitive Surgical is trading. Despite its strong performance, with a 3-year return of 148.11% compared to the S&P 500's 78.85%, the high valuation metrics suggest that the stock may not be a prudent investment at current levels. The company's returns have outpaced the benchmark in the short term, but the elevated valuation ratios raise concerns about future growth sustainability....

Is Intuitive Surgical, Inc. technically bullish or bearish?

2025-10-26 11:26:36

As of 24 October 2025, the technical trend for Intuitive Surgical, Inc. has changed from mildly bearish to sideways. The current stance is neutral, with mixed signals across different indicators. The weekly MACD is mildly bullish, while the monthly MACD is mildly bearish. Bollinger Bands indicate bullishness in both weekly and monthly time frames. However, the daily moving averages are mildly bearish, and the KST shows bearish signals in both weekly and monthly periods. The Dow Theory reflects a mildly bullish stance on the weekly chart but is bearish on the monthly. In terms of performance, Intuitive Surgical has outperformed the S&P 500 over the past week and month, with returns of 22.50% and 23.09% respectively, while the S&P 500 returned 1.92% and 2.32%. However, over longer periods, such as YTD and 1Y, the company has underperformed the benchmark. Overall, the mixed indicators suggest a cautious appr...

Is Intuitive Surgical, Inc. overvalued or undervalued?

2025-10-26 11:08:37

As of 24 October 2025, the valuation grade for Intuitive Surgical, Inc. has moved from very expensive to expensive. The company appears overvalued based on its current valuation metrics. Key ratios include a P/E ratio of 80, an EV to EBITDA of 66.13, and a PEG ratio of 3.60, all of which are significantly higher than its peers, such as Abbott Laboratories with a P/E of 18.36 and Thermo Fisher Scientific with an EV to EBITDA of 21.65. In comparison to the broader market, Intuitive Surgical has shown strong short-term performance, with a 1-week return of 22.50% compared to the S&P 500's 1.92%, but its year-to-date return of 4.70% lags behind the S&P 500's 15.47%. This suggests that despite recent gains, the company's high valuation ratios indicate it may not be justified given its performance relative to both peers and the market....

Intuitive Surgical Stock Soars 13.89%, Hits Intraday High of $549.85

2025-10-23 17:32:13

Intuitive Surgical, Inc. has seen notable stock activity, with a substantial increase today and impressive gains over the past week and month. The company demonstrates strong long-term growth, high institutional holdings, and solid operational metrics, reflecting its resilience and potential within the Pharmaceuticals & Biotechnology sector.

Intuitive Surgical, Inc. Experiences Revision in Its Stock Evaluation Amid Market Challenges

2025-10-13 15:40:02

Intuitive Surgical, Inc. has recently adjusted its valuation, with its stock price at $429.59, down from $443.76. Over the past year, the company has underperformed the S&P 500. Key financial metrics indicate a premium valuation, with a P/E ratio of 80 and a return on capital employed of 19.51%.

Is Intuitive Surgical, Inc. overvalued or undervalued?

2025-10-12 11:08:24

As of 10 October 2025, the valuation grade for Intuitive Surgical, Inc. has moved from expensive to fair. The company appears to be fairly valued based on its current metrics, with a P/E ratio of 80, a Price to Book Value of 11.67, and an EV to EBITDA of 66.13. In comparison to peers, Abbott Laboratories has a P/E of 18.36, while Thermo Fisher Scientific, Inc. has a P/E of 30.06, indicating that Intuitive Surgical is trading at a premium relative to these companies. Despite the recent shift in valuation, Intuitive Surgical has underperformed compared to the S&P 500, with a year-to-date return of -17.70% versus the S&P 500's 11.41%. This underperformance, along with the high valuation ratios, suggests that while the stock is currently fairly valued, it may face challenges in justifying its premium in the near term....

View All News